Company Encyclopedia
View More
name
iShares Global Healthcare
IXJ.US
News
View More

AbbVie Inc. Stock Outperforms Competitors On Strong Trading Day

AbbVie Inc. shares rose 1.80% to $226.82, outperforming competitors on a strong trading day. The S&P 500 Index increased by 0.88% and the Dow Jones Industrial Average by 0.38%. AbbVie is 7.35% below its 52-week high of $244.81. Competitors' performance: Johnson & Johnson fell 0.93%, Pfizer rose 0.60%, and Amgen rose 0.91%. Trading volume was 18.6M, above the 50-day average of 5.6M.

Dow Jones·
US
ABBV
+1.80%
Dow Jones·
US
ABBV
+1.80%

Lilly shares have tripled on weight-loss drugs. Why the stock looks cheap.

The growth potential of the weight-loss market could explode with advances, notably GLP-1 pills, and broader insurance coverage. That should change both health outcomes and the way Americas buy and consume food.

MSN·
US
LLY
+1.38%
MSN·
US
LLY
+1.38%

Dow Jones' Merck, other drugmakers strike drug-pricing bargains with Trump

Dow Jones stock Merck and eight other bellwether pharma companies struck drug-pricing agreements with the Trump administration on Friday.

MSN·
US
MRK
+0.40%
MSN·
US
MRK
+0.40%

US FDA grants priority vouchers to Merck's cholesterol pill, cancer therapy

Dec 19 (Reuters) - The U.S. Food and ‌Drug ​Administration said on ‍Friday it ⁠has ⁠granted national ‌priority ​vouchers to Merck's ( MRK ) cholesterol ⁠pill ‍and ​its cancer therapy, making them ‍the latest additions to the ​fast-track ‍program. (Reporting by ​Siddhi Mahatole and Mariam Sunny in Bengaluru; Editing ​by Leroy Leo and ‍Shailesh Kuber)

fidelity·
US
MRK
+0.40%
fidelity·
US
MRK
+0.40%

UnitedHealth Commits to Improvements in Business Practices Following Initial Independent Audit Findings

UnitedHealth Group is implementing measures to enhance business processes after audits by FTI Consulting and Analysis Group. The audits reviewed risk assessment operations in Medicare Advantage programs and Optum Rx's prescription drug discount policies. UnitedHealth has developed 23 action plans to address findings, aiming for full implementation by Q1 2026. The company emphasizes transparency and continuous improvement, impacting patients and the health system. UnitedHealth shares fell 0.1% in late-afternoon trade, with a 35% loss this year.

fidelity·
US
UNH
-0.22%
fidelity·
US
UNH
-0.22%
© 2025 Longbridge｜Disclaimer